In most vaccine recipients, a candidate dengue vaccine developed by NIH scientists was found to be safe and stimulate a strong immune response, show clinical trial results. The trial results were published online on January 17 in the iJournal of Infectious Diseases/i. Dengue fever, prevalent in many tropical and subtropical regions of the world, is caused by any of four related viruses-DENV-1, DENV-2, DENV-3 and DENV-4 -that are transmitted to humans by Aedes ...Thursday, 24 January 2013
Candidate Dengue Vaccine Shows Promise
In most vaccine recipients, a candidate dengue vaccine developed by NIH scientists was found to be safe and stimulate a strong immune response, show clinical trial results. The trial results were published online on January 17 in the iJournal of Infectious Diseases/i. Dengue fever, prevalent in many tropical and subtropical regions of the world, is caused by any of four related viruses-DENV-1, DENV-2, DENV-3 and DENV-4 -that are transmitted to humans by Aedes ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment